aarti drugs

How to Identify Stocks with Low Downside Risk and Potential for Large Gains?…Backed with Examples

October 15, 2020

Dear Sir, Hope you are doing well. Today, I would like to share with you our thought process on how to identify stocks with low downside risk and potential for high pay offs. I think you will agree with the following two facts: All the businesses are cyclical to varying extents and go through lean periods, and Best returns are generated when a company goes through both Earnings and PE expansion Thus, if you combine the two, we get the…

Read More

Aarti Drugs – 500% + Return in the last few months…Is it time to be Cautious?

August 31, 2020

Dear Sir, Hope you are doing well. It’s always to great to have stocks that end up multiplying your wealth several times; however, during one’s holding of such stocks there also comes a time when one needs to get cautious and have some profit protection strategy in place. Here, we are talking about Aarti Drugs. The stock has been a great wealth creator for our Premium Members as we could identify the stock at levels of 550 in Sep’18 and since…

Read More

7th Aug’20 – Jun’20 earnings update on Manappuram and Aarti Drugs

August 7, 2020

Dear Members, We have released 7th Aug’20 – Jun’20 earnings update on Manappuram Finance and Aarti Drugs. The same has been produced below. For other updates, please refer the following link – https://katalystwealth.com/category/latest-updates/ Date: 7th Aug’20   Manappuram Finance (NSE – MANAPPURAM) – Jul’17 Alpha stock CMP – 161.60 (BSE); 161.60 (NSE) Rating – Positive – 8% weightage; this is not an investment advice (refer rating interpretation) Source: bseindia.com Manappuram has reported decent set of numbers for Q1 FY 21; however,…

Read More

Investing in beaten down Pharma in 2017-18 has given us two 30% + CAGR stocks

June 5, 2020

Dear Sir, If you have been reading our mails, you might be aware that we have been extensively focusing on beaten down stocks/sectors wherein the companies have strong balance sheets and will probably emerge stronger from this crisis. The thesis behind the same is simple: Since the bear market that started in Jan’18 and accentuated by covid-19 crisis, a lot of stocks have corrected to levels wherein the market is assuming that companies won’t survive. It is true that some…

Read More